Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.425 USD | +1.03% | +9.51% | -10.38% |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.38% | 180M | |
+47.33% | 54.63B | |
-6.72% | 39.92B | |
+37.07% | 38.82B | |
+13.90% | 26.86B | |
-11.17% | 26.22B | |
-21.88% | 18.78B | |
+25.96% | 12.21B | |
+0.75% | 12.16B | |
+26.72% | 11.94B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating